Photo of Joseph F. Quinn, M.D.

Joseph F. Quinn M.D.

    • Professor of Neurology School of Medicine
    • Director OHSU Parkinson Center and Movement Disorders Program School of Medicine
    • Director, Portland VAMC Parkinson’s Disease Research, Education, and Clinical Center (PADRECC)
    • Neuroscience Graduate Program School of Medicine

Director of the OHSU Parkinson Center and Movement Disorder Program

Director of the Portland VAMC Parkinson’s Disease Research, Education, and Clinical Center (PADRECC)

Professor of Neurology, OHSU School of Medicine

Dr. Quinn is NIH and VA-funded to conduct translational research in neurodegenerative disease, including work with animal models, biomarkers, and clinical trials. His research focus is on cognitive decline in Parkinson’s disease and other neurodegenerative diseases.

Read more
  • Residency:

    • Neurology-Oregon Health & Science University, Portland
  • Fellowship:

    • Geriatric neurology-VAMC Portland

Publications

  • "Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states." Scientific Reports  In: , Vol. 8, No. 1, 4103, 01.12.2018.
  • "Centella asiatica attenuates hippocampal mitochondrial dysfunction and improves memory and executive function in β-amyloid overexpressing mice." Molecular and Cellular Neuroscience  In: , Vol. 93, 01.12.2018, p. 1-9.
  • "Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease." Scientific Reports  In: , Vol. 8, No. 1, 13807, 01.12.2018.
  • "Sex-specific genetic predictors of Alzheimer’s disease biomarkers." Acta Neuropathologica  In: , Vol. 136, No. 6, 01.12.2018, p. 857-872.
  • "Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference." Nature communications  In: , Vol. 9, No. 1, 4273, 01.12.2018.
  • "Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti--Synuclein Monoclonal Antibody, in Patients with Parkinson Disease : A Randomized Clinical Trial." JAMA Neurology  In: , Vol. 75, No. 10, 01.10.2018, p. 1206-1214.
  • "A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson’s disease : Does age matter?" PloS one  In: , Vol. 13, No. 9, e0203637, 01.09.2018.
  • "Sex-specific association of apolipoprotein e with cerebrospinal fluid levels of tau." JAMA Neurology  In: , Vol. 75, No. 8, 01.08.2018, p. 989-998.
  • "Centella asiatica increases hippocampal synaptic density and improves memory and executive function in aged mice." Brain and Behavior  In: , Vol. 8, No. 7, e01024, 01.07.2018.
  • "Analysis of shared heritability in common disorders of the brain." Science  In: , Vol. 360, No. 6395, 8757, 22.06.2018.
  • "CNS Langerhans cell histiocytosis : Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions." Cancer  In: , Vol. 124, No. 12, 15.06.2018, p. 2607-2620.
  • "Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease." Parkinsonism and Related Disorders  In: , 01.01.2018.
  • "Lost in Translation? Finding Our Way to Effective Alzheimer's Disease Therapies." Journal of Alzheimer's Disease  In: , Vol. 64, No. s1, 01.01.2018, p. S33-S39.
  • "Diagnosis, treatment, and clinical outcomes in 43 cases with cerebrotendinous xanthomatosis." Journal of Clinical Lipidology  In: , 01.01.2018.
  • "Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia." International Journal of Geriatric Psychiatry  In: , Vol. 33, No. 5, 01.01.2018, p. 763-768.
  • "The key role of T cells in Parkinson's disease pathogenesis and therapy." Parkinsonism and Related Disorders  In: , 01.01.2018.
  • "Analytics of Cerebrospinal Fluid MicroRNA Quantitative PCR Studies." Molecular Neurobiology  In: , 01.01.2018.
  • "Alternating Thalamic Deep Brain Stimulation for Essential Tremor : A Trial to Reduce Habituation." Movement Disorders Clinical Practice  In: , 01.01.2018.
  • "Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia." Molecular Neurobiology  In: , 01.01.2018.
  • "Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease." Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring  In: , Vol. 10, 01.01.2018, p. 595-598.
  • "Version 3 of the national Alzheimer's coordinating center's uniform data set." Alzheimer Disease and Associated Disorders  In: , Vol. 32, No. 4, 01.01.2018, p. 351-358.
  • "Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale-2 in Parkinson's disease." Movement Disorders  In: , 01.01.2018.
  • "Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features." Scientific Reports  In: , Vol. 7, No. 1, 8137, 01.12.2017.
  • "Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty." Scientific Reports  In: , Vol. 7, No. 1, 14052, 01.12.2017.
  • "Analysis of extracellular RNA in cerebrospinal fluid." Journal of Extracellular Vesicles  In: , Vol. 6, No. 1, 1317577, 01.12.2017.
  • "Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians." Psychopharmacology  In: , 29.11.2017, p. 1-10.
  • "Centella asiatica : phytochemistry and mechanisms of neuroprotection and cognitive enhancement." Phytochemistry Reviews  In: , 20.09.2017, p. 1-34.
  • "The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease." Alzheimer's and Dementia: Translational Research and Clinical Interventions  In: , Vol. 3, No. 3, 01.09.2017, p. 348-359.
  • "Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease." Nature Genetics  In: , Vol. 49, No. 9, 01.09.2017, p. 1373-1384.
  • "Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease." Neurobiology of Aging  In: , Vol. 56, 01.08.2017, p. 211.e1-211.e7.

Additional information

Edit profile